Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by Sarb99on Apr 18, 2021 3:27pm
202 Views
Post# 33019386

Here are upcoming updates in the next 2-4 weeks

Here are upcoming updates in the next 2-4 weeks

Here are the upcoming updates that should help Medivolve generate revenue for the future. 

 

  1. According to the webinar, we should get an update from Blowfish in the next week or two. 
  2. Home testing can be a big addition. Especially if they manage to sign deals with big box stores and start selling online. (How many other covid plays are dying to develop and then get FDA approval to sell home testing kits) https://stockhouse.com/news/press-releases/2021/04/08/collection-sites-makes-affordable-fda-eua-approved-covid-19-at-home-testing
  3. HRSA Govt funded covid testing and vaccine is a good addition to add uninsured and undocumented clients. (How many other companies are trying to get Govt contract) No cost tests are already added to the https://testbeforeyougo.com/ as coming soon
  4. Vaccine contract should be long-term revenue-generating as people need a booster shot every 6-12 months https://www.biospace.com/article/pfizer-ceo-another-covid-19-vaccine-will-likely-be-needed-in-12-months/ 
  5. Nuturell can bring in add-on Revenue 
  6. Financial should add trust in the company that has already generated revenue. 
  7. Telehealth Projects is to assure investors of the long-term plan. According to Doug in the webinar first delivery of the pieces of equipment is expected next week. 
<< Previous
Bullboard Posts
Next >>